Table 2 Patients’ clinicopathologic parameters
In situ(n = 68), n(%) | Ex situ(n = 118), n(%) | Splenectomy(n = 31),n(%) | Pvalue | |
|---|---|---|---|---|
Gender | 0.238 | |||
Male | 47(69.1) | 91(77.1) | 26(83.9) | |
Female | 21(30.9) | 27(22.9) | 5(16.1) | |
Age | 1.000 | |||
< 60 | 36(52.9) | 63(53.4) | 17(54.8) | |
≥ 60 | 32(47.1) | 55(46.6) | 14(45.2) | |
BMI | 0.716 | |||
< 19 | 5(7.4) | 10(8.5) | 1(3.2) | |
~ <25 | 46(67.6) | 83(70.3) | 22(71.0) | |
~ <30 | 17(25) | 22(18.6) | 7(22.6) | |
≥ 30 | 0(0) | 3(2.5) | 1(3.2) | |
NACT | 0.008 | |||
No | 42(61.8) | 48(40.7) | 11(35.5) | |
Yes | 26(38.2) | 70(59.3) | 20(64.5) | |
Degree of LND | 0.090 | |||
D1+ | 5(7.4) | 7(5.9) | 1(3.2) | |
D2 | 58(85.3) | 84(71.2) | 23(74.2) | |
D2+ | 5(7.4) | 27(22.9) | 7(22.6) | |
Gastrectomy | 0.033 | |||
Proximal | 28(41.2) | 34(28.8) | 5(16.1) | |
Total | 40(58.8) | 84(71.2) | 26(83.9) | |
Differentiation | 0.115 | |||
Well | 1(1.5) | 9(7.6) | 5(16.1) | |
Moderate | 31(45.6) | 53(44.1) | 12(38.7) | |
Poor | 36(52.9) | 57(48.3) | 14(45.2) | |
LVI | 0.060 | |||
No | 26(38.8) | 66(55.9) | 12(41.4) | |
Yes | 41(61.2) | 52(44.1) | 17(58.6) | |
Location | 0.648 | |||
EGJ | 35(51.5) | 63(53.4) | 12(38.7) | |
U/UM | 7(10.3) | 10(8.5) | 6(19.4) | |
M/MU | 24(35.3) | 43(36.4) | 12(38.7) | |
EUM | 2(2.9) | 2(1.7) | 1(3.2) | |
Tumor size | 0.548 | |||
≤ 2 cm | 7(10.3) | 10(8.5) | 2(6.5) | |
~ ≤5 cm | 35(51.5) | 56(47.5) | 10(32.2) | |
~ ≤10 cm | 21(30.9) | 40(33.9) | 14(45.2) | |
> 10 cm | 5(7.4) | 12(10.2) | 5(16.1) | |
Multi-tumor | 0.095 | |||
No | 68(100) | 115(97.5) | 29(93.5) | |
Yes | 0 | 3(2.5) | 2(6.5) | |
T stagea | 0.059 | |||
T2 | 5(7.4) | 11(9.3) | 2(6.5) | |
T3 | 5(7.4) | 1(0.8) | 1(3.2) | |
T4a | 51(75.0) | 101(85.6) | 23(74.2) | |
T4b | 7(10.3) | 5(4.2) | 5(16.1) | |
N stagea | 0.230 | |||
N0 | 8(11.8) | 35(29.7) | 5(16.1) | |
N1 | 13(19.1) | 16(13.6) | 7(22.6) | |
N2 | 16(23.5) | 26(22.0) | 6(19.4) | |
N3a | 18(26.5) | 21(17.8) | 8(25.8) | |
N3b | 13(19.1) | 20(16.9) | 5(16.1) |